IP Library › Granted Patent US 9,446,108
Granted Patent B2
US 9,446,108 · App. 14/401,257 · Granted Sep 20, 2016

Fish vaccine

Inventor: Henning Sorum (Oslo, NO)
Assignee: NORGES MILIØ-OG BIOVITENSKAPELIGE UNIVERSITET (NMBU
A61K39/0208A61K39/107A61K39/116C07K16/1239A61K2039/521A61K2039/552A61K2039/70
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,446,108
App. No.
14/401,257
Granted
Sep 20, 2016
Kind
B2
Abstract

The present invention relates to novel compositions for medical use, particularly for use as vaccines. The present invention relies upon the dependence of the bacteria of the species Alliivibrio wodanis (formerly Vibrio wodanis ) in the pathogenesis in the unrecognized, novel disease wodanosis (Norwegian: odinose), as well as in the chronic disease stages of winter ulcer in a composition together with Moritella viscosa ( M. viscosa ). in addition, it is also related herein to a composition comprising inactivated bacteria of one or more culture(s) of the species M. viscosa cultivated in physical contact with cells of A. wodanis to improve the technical composition and protection of a vaccine against winter ulcer. The invention also relates to use of such vaccine compositions in prevention and/or treatment of wodanosis and winter ulcer, methods for the production of such vaccines, and to methods for preventing, controlling and combating Alliivibno wodanis infection and chronic winter ulcer in fish.

Claims (35)

1. A method for preventing and/or treating wodanosis in a fish, comprising administering an effective amount of a composition comprising inactivated bacteria of one or more mixed culture(s) of spp. Alliivibrio wodanis ( A. wodanis ) and Moritella viscosa ( M. viscosa ) to a fish, wherein said mixed culture of spp. A. wodanis and M. viscosa comprises cells of A. wodanis and M. viscosa that are cultured in a way that creates physical cell-cell contact between said A. wodanis and M. viscosa cells and/or cultured in the presence of extracellular components from individual or mixed cultures of M. viscosa and A. wodanis , and wherein said effective amount is sufficient to trigger an immune response in said fish.

2. The method according to claim 1 , wherein said inactivated bacteria have been obtained from one or more mixed cultures of A. wodanis and M. viscosa which have been cultivated at a temperature of about 10-12° C. (high).

3. The method according to claim 1 , wherein said inactivated bacteria have been obtained from one or more mixed cultures of A. wodanis and M. viscosa which have been cultivated at a temperature of about 7-8° C. (low).

4. The method according to claim 1 , wherein said inactivated bacteria have been obtained from one or mixed cultures of A. wodanis and M. viscosa which have been cultivated at a salt concentration of about 0.9% (low).

5. The method according to claim 1 , wherein said inactivated bacteria have been obtained from one or more mixed cultures of A. wodanis and M. viscosa which have been cultivated at a salt concentration of about 2.5% (high).

6. The method according to claim 1 , wherein said composition further comprises an adjuvant and/or a pharmaceutically acceptable excipient.

7. The method according to claim 1 , wherein said fish is a salmonid (Salmonidae) selected from the group consisting of salmon, Atlantic salmon, or rainbow trout; or atlantic cod, turbot or fish of the species Labridae.

8. The method according to claim 1 , wherein said administration is performed by intraperitoneal injection, by bath vaccination, or by oral vaccination.

9. The method according to claim 1 , wherein said composition further comprises inactivated bacteria of a single culture of spp. A. wodanis and/or M. viscosa.

10. The method according to claim 9 , wherein said A. wodanis and/or M. viscosa has been cultivated at a temperature of about 10-12° C. (high).

11. The method according to claim 9 , wherein said A. wodanis and/or M. viscosa has been cultivated at a temperature of about 7-8° C. (low).

12. The method according to claim 9 , wherein said A. wodanis and/or M. viscosa has been cultivated at a salt concentration of about 0.9% (low).

13. The method according to claim 9 , wherein said A. wodanis and/or M. viscosa has been cultivated at a salt concentration of about 2.5% (high).

14. The method of claim 1 , wherein said fish is further infected with winter ulcer and said administering treats and/or prevents said winter ulcer.

15. A method for preventing and/or treating wodanosis in a fish, comprising administering an effective amount of a composition, wherein said composition comprises inactivated bacteria obtained from:

a) one or more single culture(s) of A. wodanis cultured at a temperature of about 10° C., and at a sodium salt concentration of about 0.9% salt,

b) one or more mixed culture(s) of A. wodanis and M. viscosa cultured at a temperature of about 10° C. and at a sodium salt concentration of about 0.9%, and

c) optionally one or more single culture(s) of M. viscosa cultured at a temperature of about 10° C. and at a sodium salt concentration of about 0.9%,

wherein said effective amount is sufficient to trigger an immune response in said fish.

16. A method for preventing and/or treating a co-infection of wodanosis and winter ulcer in a fish, comprising administering an effective amount of a composition, wherein said composition comprises inactivated bacteria obtained from:

a) one or more single culture(s) of M. viscosa cultured at a temperature of about 8° C. and a sodium salt concentration of about 0.9% salt,

b) one or more single culture(s) of M. viscosa cultured at a temperature of about 8° C. and a sodium salt concentration of about 2.5% salt,

c) one or more single culture(s) of A. wodanis cultured at a temperature of about 10° C. and a sodium salt concentration of about 0.9%,

d) one or more single culture(s) of A. wodanis cultured at a temperature of about 10° C. and a sodium salt concentration of about 2.5%,

e) one or more mixed culture(s) of M. viscosa and A. wodanis cultured at a temperature of about 8° C., and a sodium salt concentration of about 0.9%,

f) one or more mixed culture(s) of M. viscosa and A. wodanis cultured at a temperature of about 8° C. and a salt concentration of about 2.5%,

g) one or more mixed culture(s) of M. viscosa and A. wodanis cultured at a temperature of about 10° C. and a salt concentration of about 0.9%,

h) one or more mixed culture(s) of M. viscosa and A. wodanis cultured at a temperature of about 10° C. and a sodium salt concentration of about 2.5%, and optionally

i) inactivated bacteria obtained from one or more single culture(s) of A. wodanis cultured at a temperature of about 8° C. and a salt concentration of about 2.5%, and further optionally

j) inactivated bacteria obtained from one or more single culture(s) of A. wodanis cultured at a temperature of about 8° C. and a sodium salt concentration of about 0.9%, and further optionally

k) inactivated bacteria obtained from one or more single culture(s) of M. viscosa cultured at about 10° C., and at a sodium salt concentration of 2.5% salt, and further optionally

l) inactivated bacteria obtained from one or more single culture(s) of M. viscosa cultured at about 10° C. and at a sodium salt concentration of about 0.9% salt,

wherein said effective amount is sufficient to trigger an immune response in said fish.

17. The method of claim 4 , wherein said salt is sodium.

18. The method of claim 5 , wherein said salt is sodium.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2018
From: NORGES MILJØ- OG BIOVITENSKAPELIGE UNIVERSITET (NMBU)
To: PREVIWO AS
Reel/Frame 044751/0414 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 6, 2015
From: SØRUM, HENNING
To: NORGES MILJØ- OG BIOVITENSKAPELIGE UNIVERSITET (NMBU)
Reel/Frame 034903/0842 →
Priority Claims (1)
NO 20120561 · May 14, 2012 · national
Continuity (2)
Provisional Application 61646388 · May 14, 2012
Related Publication 20150132341A1 · May 14, 2015